Pair of European start-ups launch with innovative antibodies: Finance Report

This week’s launches included a pair of European start-ups with innovative antibodies, as well as an ambitious newco backed by Flagship Pioneering aiming to use AI to intercept diseases early and halt their progression.

Emerging from Versant Ventures’ Ridgeline discovery operation in Switzerland was Granite Bio AG, which has raised two rounds totaling $100 million: a $30 million series A led by Versant and Novartis Venture Fund, and a $70 million series B with Forbion and Sanofi Ventures leading...